Co-chairs the Life Sciences group. Focuses practice on FDA regulation of pharmaceuticals, biologics, and medical devices. Expertise coverGreg Levine, chair of the FDA regulatory practice group, focuses his practice on FDA regulation of pharmaceuticals, biotechnology and medical devices. Greg represents clients before state and federal regulators on all phases of the product lifecycle and is currently guiding clients through the development of laboratory diagnostics, therapeutics and vaccines related to COVID-19. In connection with the pandemic, he also counsels medical centers on emerging public health guidance. Greg regularly assists with both internal and government compliance investigations and enforcement actions. He also advises manufacturers of other FDA-regulated products, including cosmetics and dietary supplements, on a broad range of issues under the Food, Drug, and Cosmetic Act and related laws.
Prior to joining Ropes & Gray, Greg was a partner at an international law firm in Washington, D.C. He is also a former legislative staff member in the U.S. House of Representatives, where he worked on FDA-related legislation, policy, and appropriations.
BA, magna cum laude, Brown University 1990; JD, magna cum laude, Georgetown University Law Center, 1996.